

Renal Denervation Treatment Market Scope: Industry Analysis, Market Size, Growth, Trends Till
Request Sample Report
The Renal Denervation Treatment market research report provides a comprehensive analysis of market conditions, trends, and key players in the industry. The market size for Renal Denervation Treatment is estimated to be around $200 million, with strong growth potential driven by increasing prevalence of hypertension and favorable reimbursement policies.
◍ Abbott
◍ ReCor Medical
◍ Boston Scientific
◍ Cardiosonic
◍ Medtronic
◍ Kona medical
◍ Mercator Medsystems
◍ Terumo Corporation
◍ Abbott Laboratories
◍ Theragenics Corporation
The competitive landscape of the renal denervation treatment market includes key players such as Abbott, ReCor Medical, Boston Scientific, Cardiosonic, Medtronic, Kona Medical, Mercator MedSystems, Terumo Corporation, Abbott Laboratories, and Theragenics Corporation. These companies develop innovative technologies and devices for renal denervation procedures, contributing to market growth.
- Abbott: $33.1 billion in sales revenue
- Boston Scientific: $10.7 billion in sales revenue
- Medtronic: $30.1 billion in sales revenue
Request Sample Report
Hospitals
Ambulatory Surgical Centers
Others
Request Sample Report
Radiofrequency
Ultrasound
Request Sample Report
$ 611.81 Million